Taysha Gene Therapies, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2019 | $150.0K | $15.0K | — |
| FY2020 | $7.6M | $258.9M | $251.3M |
| FY2021 | $118.6M | $214.0M | $149.1M |
| FY2022 | $125.3M | $126.3M | $87.9M |
| FY2023 | $97.8M | $172.7M | $143.9M |
| FY2024 | $88.8M | $160.4M | $139.0M |
| FY2025 | $96.4M | $343.3M | $319.8M |